Middle East respiratory syndrome
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2020-03, Vol.395 (10229), p.1063-1077 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1077 |
---|---|
container_issue | 10229 |
container_start_page | 1063 |
container_title | The Lancet (British edition) |
container_volume | 395 |
creator | Memish, Ziad A Perlman, Stanley Van Kerkhove, Maria D Zumla, Alimuddin |
description | The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention. |
doi_str_mv | 10.1016/S0140-6736(19)33221-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7155742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673619332210</els_id><sourcerecordid>2424143382</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-2bdd5c235cae303361b5f855cb69289fd8465ef5cbf55239e6c2700acf55442e3</originalsourceid><addsrcrecordid>eNqFkUtLAzEUhYMotlZ_glJwUxejec5jo0ipD1BcqOAupMkdTZlOajJT6L83fVjUjatwyXfPvecehI4JPieYpBfPmHCcpBlLB6Q4Y4xSkuAd1CU844ng2dsu6m6RDjoIYYIx5ikW-6jDKOGC5KKL-o_WmAr6IxWavocws141zi_6YVEb76ZwiPZKVQU42rw99HozehneJQ9Pt_fD64dEx2FNQsfGCE2Z0AoYZiwlY1HmQuhxWtC8KE3OUwFlrEshKCsg1TTDWOlYck6B9dDlWnfWjqdgNNSNV5WceTtVfiGdsvL3T20_5Luby4wIkXEaBQYbAe8-WwiNnNqgoapUDa4NkrKMs-gaFxE9_YNOXOvraE9STjnhjOVLQbGmtHcheCi3yxAslxnIVQZyeWBJCrnKQOLYd_LTybbr--gRuFoDEO85t-Bl0BZqDcZ60I00zv4z4gtmt5UH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424143382</pqid></control><display><type>article</type><title>Middle East respiratory syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Memish, Ziad A ; Perlman, Stanley ; Van Kerkhove, Maria D ; Zumla, Alimuddin</creator><creatorcontrib>Memish, Ziad A ; Perlman, Stanley ; Van Kerkhove, Maria D ; Zumla, Alimuddin</creatorcontrib><description>The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(19)33221-0</identifier><identifier>PMID: 32145185</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Adult ; Animals ; Antibodies, Monoclonal - therapeutic use ; Antiviral Agents - therapeutic use ; Camelus ; Child ; Clinical Laboratory Techniques ; Coronavirus Infections - epidemiology ; Coronavirus Infections - prevention & control ; Coronavirus Infections - transmission ; Coronaviruses ; COVID-19 ; Critical Care ; Cross Infection - epidemiology ; Cross Infection - prevention & control ; Cross Infection - transmission ; Drug development ; Epidemics ; Epidemiology ; Fatalities ; Female ; Global Health ; Hospitals ; Humans ; Immunity, Innate - physiology ; Immunocompromised Host ; Infection Control ; Middle East respiratory syndrome ; Middle East Respiratory Syndrome Coronavirus ; Mortality ; Nosocomial infection ; Outbreaks ; Pathogenesis ; Pathogens ; Plasma ; Pregnancy ; Pregnancy Complications, Infectious - epidemiology ; Pregnancy Complications, Infectious - prevention & control ; Respiratory diseases ; Risk Factors ; Seminar ; Travel ; Vaccines ; Viral Vaccines ; Zoonoses ; Zoonoses - transmission</subject><ispartof>The Lancet (British edition), 2020-03, Vol.395 (10229), p.1063-1077</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><rights>2020. Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-2bdd5c235cae303361b5f855cb69289fd8465ef5cbf55239e6c2700acf55442e3</citedby><cites>FETCH-LOGICAL-c547t-2bdd5c235cae303361b5f855cb69289fd8465ef5cbf55239e6c2700acf55442e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673619332210$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32145185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Memish, Ziad A</creatorcontrib><creatorcontrib>Perlman, Stanley</creatorcontrib><creatorcontrib>Van Kerkhove, Maria D</creatorcontrib><creatorcontrib>Zumla, Alimuddin</creatorcontrib><title>Middle East respiratory syndrome</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Camelus</subject><subject>Child</subject><subject>Clinical Laboratory Techniques</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronavirus Infections - prevention & control</subject><subject>Coronavirus Infections - transmission</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Critical Care</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - prevention & control</subject><subject>Cross Infection - transmission</subject><subject>Drug development</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Fatalities</subject><subject>Female</subject><subject>Global Health</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immunity, Innate - physiology</subject><subject>Immunocompromised Host</subject><subject>Infection Control</subject><subject>Middle East respiratory syndrome</subject><subject>Middle East Respiratory Syndrome Coronavirus</subject><subject>Mortality</subject><subject>Nosocomial infection</subject><subject>Outbreaks</subject><subject>Pathogenesis</subject><subject>Pathogens</subject><subject>Plasma</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - epidemiology</subject><subject>Pregnancy Complications, Infectious - prevention & control</subject><subject>Respiratory diseases</subject><subject>Risk Factors</subject><subject>Seminar</subject><subject>Travel</subject><subject>Vaccines</subject><subject>Viral Vaccines</subject><subject>Zoonoses</subject><subject>Zoonoses - transmission</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUtLAzEUhYMotlZ_glJwUxejec5jo0ipD1BcqOAupMkdTZlOajJT6L83fVjUjatwyXfPvecehI4JPieYpBfPmHCcpBlLB6Q4Y4xSkuAd1CU844ng2dsu6m6RDjoIYYIx5ikW-6jDKOGC5KKL-o_WmAr6IxWavocws141zi_6YVEb76ZwiPZKVQU42rw99HozehneJQ9Pt_fD64dEx2FNQsfGCE2Z0AoYZiwlY1HmQuhxWtC8KE3OUwFlrEshKCsg1TTDWOlYck6B9dDlWnfWjqdgNNSNV5WceTtVfiGdsvL3T20_5Luby4wIkXEaBQYbAe8-WwiNnNqgoapUDa4NkrKMs-gaFxE9_YNOXOvraE9STjnhjOVLQbGmtHcheCi3yxAslxnIVQZyeWBJCrnKQOLYd_LTybbr--gRuFoDEO85t-Bl0BZqDcZ60I00zv4z4gtmt5UH</recordid><startdate>20200328</startdate><enddate>20200328</enddate><creator>Memish, Ziad A</creator><creator>Perlman, Stanley</creator><creator>Van Kerkhove, Maria D</creator><creator>Zumla, Alimuddin</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200328</creationdate><title>Middle East respiratory syndrome</title><author>Memish, Ziad A ; Perlman, Stanley ; Van Kerkhove, Maria D ; Zumla, Alimuddin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-2bdd5c235cae303361b5f855cb69289fd8465ef5cbf55239e6c2700acf55442e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Camelus</topic><topic>Child</topic><topic>Clinical Laboratory Techniques</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronavirus Infections - prevention & control</topic><topic>Coronavirus Infections - transmission</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Critical Care</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - prevention & control</topic><topic>Cross Infection - transmission</topic><topic>Drug development</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Fatalities</topic><topic>Female</topic><topic>Global Health</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immunity, Innate - physiology</topic><topic>Immunocompromised Host</topic><topic>Infection Control</topic><topic>Middle East respiratory syndrome</topic><topic>Middle East Respiratory Syndrome Coronavirus</topic><topic>Mortality</topic><topic>Nosocomial infection</topic><topic>Outbreaks</topic><topic>Pathogenesis</topic><topic>Pathogens</topic><topic>Plasma</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - epidemiology</topic><topic>Pregnancy Complications, Infectious - prevention & control</topic><topic>Respiratory diseases</topic><topic>Risk Factors</topic><topic>Seminar</topic><topic>Travel</topic><topic>Vaccines</topic><topic>Viral Vaccines</topic><topic>Zoonoses</topic><topic>Zoonoses - transmission</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Memish, Ziad A</creatorcontrib><creatorcontrib>Perlman, Stanley</creatorcontrib><creatorcontrib>Van Kerkhove, Maria D</creatorcontrib><creatorcontrib>Zumla, Alimuddin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Memish, Ziad A</au><au>Perlman, Stanley</au><au>Van Kerkhove, Maria D</au><au>Zumla, Alimuddin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Middle East respiratory syndrome</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2020-03-28</date><risdate>2020</risdate><volume>395</volume><issue>10229</issue><spage>1063</spage><epage>1077</epage><pages>1063-1077</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32145185</pmid><doi>10.1016/S0140-6736(19)33221-0</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 2020-03, Vol.395 (10229), p.1063-1077 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7155742 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenal Cortex Hormones - therapeutic use Adult Animals Antibodies, Monoclonal - therapeutic use Antiviral Agents - therapeutic use Camelus Child Clinical Laboratory Techniques Coronavirus Infections - epidemiology Coronavirus Infections - prevention & control Coronavirus Infections - transmission Coronaviruses COVID-19 Critical Care Cross Infection - epidemiology Cross Infection - prevention & control Cross Infection - transmission Drug development Epidemics Epidemiology Fatalities Female Global Health Hospitals Humans Immunity, Innate - physiology Immunocompromised Host Infection Control Middle East respiratory syndrome Middle East Respiratory Syndrome Coronavirus Mortality Nosocomial infection Outbreaks Pathogenesis Pathogens Plasma Pregnancy Pregnancy Complications, Infectious - epidemiology Pregnancy Complications, Infectious - prevention & control Respiratory diseases Risk Factors Seminar Travel Vaccines Viral Vaccines Zoonoses Zoonoses - transmission |
title | Middle East respiratory syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Middle%20East%20respiratory%20syndrome&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Memish,%20Ziad%20A&rft.date=2020-03-28&rft.volume=395&rft.issue=10229&rft.spage=1063&rft.epage=1077&rft.pages=1063-1077&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(19)33221-0&rft_dat=%3Cproquest_pubme%3E2424143382%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424143382&rft_id=info:pmid/32145185&rft_els_id=S0140673619332210&rfr_iscdi=true |